Image-defined risk factors in unresectable neuroblastoma: SIOPEN study on incidence, chemotherapy-induced variation, and impact on surgical outcomes

1 Nov

Written By Carla Aguilera

Avanzini S, Pio L, Erminio G, Granata C, Holmes K, Gambart M, Buffa P, Castel V, Valteau Couanet D, Garaventa A, Pistorio A, Cecchetto G, Martucciello G, Mattioli G, Sarnacki S

Pediatr Blood Cancer. 2017 Nov;64(11). doi: 10.1002/pbc.26605. Epub 2017 Apr 25. PMID: 28440012.

2017

Tolerability, response and outcome of high-risk neuroblastoma patients treated with long-term infusion of anti-GD2 antibody ch14.18/CHO

Accelerating drug development for neuroblastoma - New Drug Development Strategy: an ITCC, ENCCA and Adolescents and SIOPEN project